| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 22.07B | 21.49B | 21.45B | 20.97B | 19.78B |
| Gross Profit | 8.18B | 8.12B | 7.54B | 7.50B | 7.06B |
| EBITDA | 2.81B | 2.61B | 2.52B | 2.19B | 1.89B |
| Net Income | 861.97M | 860.53M | 832.58M | 659.84M | 572.41M |
Balance Sheet | |||||
| Total Assets | 18.39B | 17.60B | 16.23B | 15.06B | 15.17B |
| Cash, Cash Equivalents and Short-Term Investments | 4.55B | 4.02B | 2.55B | 1.11B | 1.68B |
| Total Debt | 68.30M | 85.58M | 79.38M | 57.71M | 77.23M |
| Total Liabilities | 7.83B | 7.40B | 6.54B | 6.20B | 6.78B |
| Stockholders Equity | 6.90B | 6.46B | 6.02B | 5.52B | 5.16B |
Cash Flow | |||||
| Free Cash Flow | 2.17B | 2.07B | 1.80B | 259.17M | 360.41M |
| Operating Cash Flow | 3.23B | 2.85B | 2.43B | 1.14B | 1.07B |
| Investing Cash Flow | -1.06B | -560.83M | -564.43M | -851.23M | -846.64M |
| Financing Cash Flow | -1.63B | -564.93M | -609.65M | -844.13M | -496.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$487.20B | 29.83 | 44.79% | 1.73% | 22.57% | 31.01% | |
70 Outperform | HK$9.76B | 12.65 | 12.69% | 3.62% | 2.61% | -0.12% | |
69 Neutral | HK$7.47B | 15.36 | 8.86% | 1.41% | 3.16% | 78.05% | |
65 Neutral | HK$33.56B | 15.38 | 15.41% | 5.64% | 4.51% | 10.64% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | HK$6.29B | 13.00 | 7.63% | 2.21% | -3.39% | 91.63% | |
42 Neutral | HK$9.31B | -10.10 | -13.37% | 0.86% | -4.92% | 20.30% |